Common analgesic agents and their role in analgesic nephropathy: A commentary of the evidence

No Thumbnail Available
File version
Author(s)
Yaxley, Julian
Griffith University Author(s)
Primary Supervisor
Other Supervisors
Editor(s)
Date
2016
Size
File type(s)
Location
License
Abstract

An association between non-opioid analgesic agents and chronic kidney disease has long been suspected. The presumed development of chronic renal impairment following protracted excessive use of non-opioid analgesia is known as analgesic nephropathy. Many accept analgesic nephropathy as a real entity despite a paucity of robust scientific evidence. The weight of available observational literature suggests that long-term ingestion of paracetamol and combination mixtures of aspirin and paracetamol probably contribute to chronic renal impairment, however there is no convincing data to implicate non-steroidal anti-inflammatory drugs or aspirin monotherapy. While controversy persists most physicians consider all non-narcotic analgesics nephrotoxic and discourage heavy use where possible.

Journal Title

International Journal of Risk & Safety in Medicine

Conference Title
Book Title
Edition
Volume

28

Issue

4

Thesis Type
Degree Program
School
Publisher link
Patent number
Funder(s)
Grant identifier(s)
Rights Statement
Rights Statement
Item Access Status
Note
Access the data
Related item(s)
Subject

Clinical sciences

Science & Technology

Life Sciences & Biomedicine

Public, Environmental & Occupational Health

General & Internal Medicine

Persistent link to this record
Citation

Yaxley, J, Common analgesic agents and their role in analgesic nephropathy: A commentary of the evidence, International Journal of Risk & Safety in Medicine, 2016, 28 (4), pp. 189-196

Collections